The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis
Open accessAbstract
The emergence of multi- and extensively drug-resistant tuberculosis is a significant impediment to the control of this disease because treatment becomes more complex and costly. Reliable and timely drug susceptibility testing is critical to ensure that patients receive effective treatment and become noninfectious. Molecular methods can provide accurate and rapid drug susceptibility results. We used DNA sequencing to detect resistance to the first-line antituberculosis drugs isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and ethambutol (EMB) and the second-line drugs amikacin (AMK), capreomycin (CAP), kanamycin (KAN), ciprofloxacin (CIP), and ofloxacin (OFX). Nine loci were sequenced: rpoB (for resistance to RIF), katG and inhA (INH), pncA (PZA), embB (EMB), gyrA (CIP and OFX), and rrs , eis , and tlyA (KAN, AMK, and CAP). A total of 314 clinical Mycobacterium tuberculosis complex isolates representing a variety of antibiotic resistance patterns, genotypes, and geographical origins were analyzed. The molecular data were compared to the phenotypic data and the accuracy values were calculated. Sensitivity and specificity values for the first-line drug loci were 97.1% and 93.6% for rpoB , 85.4% and 100% for katG , 16.5% and 100% for inhA , 90.6% and 100% for katG and inhA together, 84.6% and 85.8% for pncA , and 78.6% and 93.1% for embB . The values for the second-line drugs were also calculated. The size and scope of this study, in numbers of loci and isolates examined, and the phenotypic diversity of those isolates support the use of DNA sequencing to detect drug resistance in the M. tuberculosis complex. Further, the results can be used to design diagnostic tests utilizing other mutation detection technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Tuberculosis Drug Resistance Mutation Database
Sandgren, A., Strong, M., Muthukrishnan, P., Weiner, B. K., Church, G. M., & Murray, M. B. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000002 · Cited by 523
(2006) · PsycEXTRA Dataset · doi:10.1037/e566482006-002 · Cited by 513
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Zaunbrecher, M. A., Sikes, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907925106 · Cited by 330
Self-citationMaus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3192-3197.2005 · Cited by 273
Self-citationEffect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis
Mariam, D. H., Mengistu, Y., Hoffner, S. E., & Andersson, D. I. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1289-1294.2004 · Cited by 247
Mutation of tlyA Confers Capreomycin Resistance in Mycobacterium tuberculosis
Maus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.571-577.2005 · Cited by 228
Self-citationMechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Aubry, A., Veziris, N., Cambau, E., Truffot-Pernot, C., Jarlier, V., & Fisher, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.104-112.2006 · Cited by 197
Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
Van Deun, A., Barrera, L., Bastian, I., Fattorini, L., Hoffmann, H., Kam, K. M., Rigouts, L., Rüsch-Gerdes, S., & Wright, A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01209-09 · Cited by 186
Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
Von Groll, A., Martin, A., Jureen, P., Hoffner, S., Vandamme, P., Portaels, F., Palomino, J. C., & da Silva, P. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00287-09 · Cited by 181
Suzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Ohno, H., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1053 · Cited by 149
Safi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-07 · Cited by 136
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 133
Hazbón, M. H., Bobadilla-del-Valle, M., Guerrero, M. I., Basil, M. V., Filliol, I., Cavatore, M., Colangeli, R., Safi, H., Billman‐Jacobe, H., Lavender, C. J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3794-3802.2005 · Cited by 125
Владиславович, М. И., Otten, T., Vyshnevskiy, B. I., & Narvskaya, O. V. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3810-3813.2002 · Cited by 109
Madison, B., Robinson-Dunn, B., George, I., Gross, W., Lipman, H., Metchock, B. G., Sloutsky, A., Washabaugh, G., Mazurek, G. H., & Ridderhof, J. C. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.3976-3979.2002 · Cited by 93
Self-citationTaniguchi, H., Chang, B., Abe, C., Nikaido, Y., Mizuguchi, Y., & Yoshida, S. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4795-4801.1997 · Cited by 91
Plinke, C. F., Cox, H. S., Заркуа, Н. Э., Karimovich, H. A., Braker, K., Diel, R., Rüsch–Gerdes, S., Feuerriegel, S., & Niemann, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq120 · Cited by 89
Sun, Z., Zhang, J., Zhang, X., Wang, S., Zhang, Y., & Li, C. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.014 · Cited by 87
Starks, A. M., Gumusboga, A., Plikaytis, B. B., Shinnick, T. M., & Posey, J. E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01357-08 · Cited by 85
Self-citationKostrub, C. F., Al-Khodairy, F. M., Ghazizadeh, H., Carr, A. M., & Enoch, T. (1997) · Molecular and General Genetics MGG · doi:10.1007/s004380050431 · Cited by 83
Via, L. E., Cho, S.-N., Hwang, S., Bang, H., Park, S. K., Kang, H. S., Jeon, D., Min, S., Oh, T., Kim, Y., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01476-09 · Cited by 74
Safi, H., Fleischmann, R. D., Peterson, S. N., Jones, M. B., Jarrahi, B., & Alland, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-09 · Cited by 61
Srivastava, S., Garg, A., Ayyagari, A., Nyati, K. K., Dhole, T. N., & Dwivedi, S. K. (2006) · Current Microbiology · doi:10.1007/s00284-006-0135-1 · Cited by 43
Srivastava, S., Ayyagari, A., Dhole, T. N., Nyati, K. K., & Dwivedi, S. K. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2008.07.001 · Cited by 41
Marttila, H., Mäkinen, J., Marjamäki, M., & Soini, H. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0584-5 · Cited by 35
Cited by
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Drug Resistance Mechanisms in Mycobacterium tuberculosis
Palomino, J., & Martin, A. (2014) · Antibiotics · doi:10.3390/antibiotics3030317 · Cited by 442
Farhat, M. R., Shapiro, B. J., Kieser, K. J., Sultana, R., Jacobson, K. R., Victor, T. C., Warren, R. M., Streicher, E. M., Calver, A., Sloutsky, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2747 · Cited by 440
Self-citationDookie, N., Rambaran, S., Padayatchi, N., Mahomed, S., & Naidoo, K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx506 · Cited by 346
Miotto, P., Tessema, B., Tagliani, E., Chindelevitch, L., Starks, A. M., Emerson, C., Hanna, D., Kim, P. S., Liwski, R., Zignol, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01354-2017 · Cited by 327
Self-citation
Metadata
- Authors
- Campbell, P. J., Morlock, G. P., Sikes, R. D., Dalton, T. L., Metchock, B., Starks, A. M., Hooks, D. P., Cowan, L. S., Plikaytis, B. B., & Posey, J. E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-05
- Volume
- 55
- Issue
- 5
- Pages
- 2032-2041
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2137758606
- Cited by
- 379
- References
- 31
- FWCI
- 23.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.